Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Peptisystems AB is currently managing 1 pending office action. This workload is assigned to 1 distinct examiner, concentrating the company's current legal interactions within a single examination path. This structure allows for a highly targeted approach to the pending application.
The busiest examiner for this portfolio is SHIAO, YIH-HORNG. This examiner is handling 1 pending office action, which constitutes the full extent of the company's pending office actions at this time. Since SHIAO, YIH-HORNG is the only examiner involved, the company can focus its resources on addressing the specific concerns raised by this individual.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SHIAO, YIH-HORNG | 1 | 72.6% | +75.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18692033 | PROCESSES AND SYSTEMS FOR FLOW-THROUGH OLIGONUCLEOTIDE SYNTHESIS | SHIAO, YIH-HORNG | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18692033 | PROCESSES AND SYSTEMS FOR FLOW-THROUGH OLIGONUCLEOTIDE SYNTHESIS | SHIAO, YIH-HORNG | — |
| Art Unit | Apps |
|---|---|
| 1691 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18692033 | PROCESSES AND SYSTEMS FOR FLOW-THROUGH OLIGONUCLEOTIDE SYNTHESIS | SHIAO, YIH-HORNG | 1691 | §102§103§112 | Non-Final OA | — | Pending | Mar 14, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialPeptisystems AB has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Yih-Horng Shiao has the most, with 1 of Peptisystems AB's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.